Infection Control Surveillance Solutions Market Report 2026

The infection control surveillance solutions market size has grown strongly in recent years. It will grow from $1.83 billion in 2025 to $2 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising incidence of healthcare-associated infections, increased regulatory focus on infection control, expansion of hospital digitization initiatives, growing use of electronic health records, demand for improved patient safety.

The infection control surveillance solutions market size is expected to see strong growth in the next few years. It will grow to $2.82 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing investments in ai-driven surveillance tools, rising adoption of cloud healthcare solutions, expansion of antimicrobial stewardship programs, growing focus on real-time data-driven decision making, increasing healthcare quality compliance requirements. Major trends in the forecast period include increasing adoption of real-time infection monitoring systems, rising use of predictive analytics for outbreak detection, growing integration with electronic health records, expansion of cloud-based surveillance platforms, enhanced focus on compliance and reporting automation.

The increasing incidence of healthcare-associated infections (HAIs) is expected to drive the growth of the infection control surveillance solutions market in the coming years. Healthcare-associated infections are infections that patients contract while undergoing treatment for medical or surgical conditions within a healthcare facility. The rise in healthcare-associated infections is attributed to the growing use of invasive medical devices, such as catheters and ventilators, which can introduce pathogens into the body. Infection control surveillance solutions help minimize healthcare-associated infections by supporting early identification of infection patterns and enabling timely interventions to prevent outbreaks. For example, in March 2025, according to the UK Health Security Agency, a UK-based government organization, it was reported that 7.6% of hospital patients in England had at least one healthcare-associated infection, with intensive care units recording the highest prevalence at 15.9%. As a result, the rising incidence of healthcare-associated infections (HAIs) is fueling the growth of the infection control surveillance solutions market.

Leading companies operating in the infection control surveillance solutions market are concentrating on developing innovative offerings, such as infection surveillance systems, to strengthen early detection and response to healthcare-associated infections. Infection surveillance systems are digital or manual solutions used to systematically track, identify, and report infections within healthcare environments to support timely prevention and control actions. For instance, in November 2023, NeoIPC, a Europe-based neonatal infection prevention initiative coordinated by Fondazione Penta ETS, introduced a new surveillance toolkit aimed at improving infection prevention and control efforts in neonatal intensive care units (NICUs). The toolkit includes real-time data collection tools specifically designed for neonatal settings, enabling early identification of infection clusters and antimicrobial resistance trends. It also offers customizable dashboards for NICU staff to monitor IPC indicators, along with integrated decision-support algorithms that support timely interventions. Additionally, it facilitates cross-institutional data sharing and benchmarking, promoting collaborative learning and quicker responses to emerging infection risks.

In February 2024, Inovalon Holdings Inc., a US-based provider of cloud-based software solutions, acquired VigiLanz Corporation for an undisclosed amount. Through this acquisition, Inovalon seeks to enhance its capabilities in real-time clinical surveillance, patient safety, and data analytics across healthcare settings. VigiLanz Corporation is a US-based company that specializes in SaaS-based clinical surveillance and patient safety software and data solutions.

Major companies operating in the infection control surveillance solutions market are Oracle Corporation, 3M Company, Becton Dickinson And Company, Baxter International Inc, Ecolab Inc, Wolters Kluwer NV, STERIS plc, Getinge AB, Premier Inc, Inovalon Holdings Inc, Belimed AG, Harris Healthcare Solutions Inc, RLDatix Group, Hygiena LLC, CenTrak Inc, Matachana Group SA, Pal International Ltd, Azalea Health Innovations Inc, TOMI Environmental Solutions Inc, Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions.

North America was the largest region in the infection control surveillance solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infection control surveillance solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infection control surveillance solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the infection control surveillance solutions market by increasing costs of imported hardware sensors, monitoring devices, network infrastructure components, and advanced analytics software. Hospitals and healthcare systems in North America and Europe are most affected due to dependence on imported digital health technologies, while Asia-Pacific faces cost pressures on technology deployment. These tariffs are raising implementation costs and delaying large-scale rollouts. However, they are also encouraging domestic software development, regional hardware manufacturing, and localized innovation in healthcare surveillance solutions.

The infection control surveillance solutions market research report is one of a series of new reports that provides infection control surveillance solutions market statistics, including infection control surveillance solutions industry global market size, regional shares, competitors with a infection control surveillance solutions market share, detailed infection control surveillance solutions market segments, market trends and opportunities, and any further data you may need to thrive in the infection control surveillance solutions industry. This infection control surveillance solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Infection control surveillance solutions refer to systems and technologies designed to monitor, track, and analyze infection patterns within healthcare settings to prevent and control the spread of infectious diseases. These solutions enable real-time data collection, reporting, and alerting to help healthcare providers implement timely interventions and ensure patient safety.

The primary product types of infection control surveillance solutions include software solutions, hardware solutions, and services. Infection control surveillance software solutions are digital platforms that monitor, analyze, and alert healthcare providers about potential healthcare-associated infections (HAIs) to support timely intervention and enhance patient safety. These solutions are offered through deployment modes such as on-premises, cloud-based, and hybrid models. They are applied across areas including infection control, surveillance and reporting, data management, compliance monitoring, and quality improvement, and are used by end users such as hospitals, long-term care facilities, home healthcare providers, ambulatory surgical centers, and clinical laboratories.

The infection control surveillance solutions market consists of revenues earned by entities by providing services such as antimicrobial stewardship support, performance metrics, cloud hosting, training, and alert and escalation workflows. The market value includes the value of related goods sold by the service provider or included within the service offering. The infection control surveillance solutions market also includes sales of antimicrobial stewardship systems, clinical decision support systems, electronic health record (EHR) integration modules, antibiotic resistance tracking tools, and outbreak detection and alert systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.